MedPath

Evaluating the effectiveness of Agoraphobia Free: A novel mobile application for treating Agoraphobia

Completed
Conditions
Agoraphobia/Agoraphobic anxiety
Mental and Behavioural Disorders
Registration Number
ISRCTN98453199
Lead Sponsor
niversity of Roehampton
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
170
Inclusion Criteria

1. Aged 18 or above
2. Identify themselves as suffering from agoraphobia
3. Willing and able to provide informed consent to participate

Exclusion Criteria

1. Inability to give informed consent due to significant cognitive or intellectual impairment
2. No adequate understanding of English as a first language
3. Not having a mobile device than can run the application as designed
4. Any significant disease or disorder which, in the opinion of the Investigators, may either put the person at risk because of participation in the trial.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of agoraphobic and panic symptoms are measured using the Panic and Agoraphobia Scale at baseline, 6 and 12 weeks.
Secondary Outcome Measures
NameTimeMethod
1. Degree of subjective distress experienced because of agoraphobia is measured by using a single item (How much distress have you experienced because of agoraphobia in the past week?”), which is rated from 1 (No distress”) to 5 (Extreme distress”) at baseline, 6 and 12 weeks<br>2. Completion of the intervention is measured as 1 (completion of the tasks) or 0 (non-completion of the tasks) at 6 and 12 weeks<br>3. Engagement with the apps is measured using app usage data (i.e. total number of times that users engaged with the app) at 6 and 12 weeks
© Copyright 2025. All Rights Reserved by MedPath